A biopharmaceutical company in Kentucky is developing a Coronavirus vaccine.
Kentucky Bioprocessing, based in Owensboro has joined the Coronavirus vaccine race and is using tobacco to do it.
The announcement was made Thursday from British American Tobacco, Kentucky Bioprocessing’s parent company.
The vaccine is currently in pre-clinical testing.
Kentucky Bioprocessing was also a major player in developing Ebola treatment.